News

This is a newly identified association between the conditions, and they may share a common underlying link.

By localizing the portion of the brain responsible for seizures and envisioning long-term outcomes, this imaging combination helps guide clinical decision making.

Many patients with brain tumors present with isolated headaches but no other symptoms. Use neuroimaging to help the diagnosis, or cut costs?

Transcranial magnetic stimulation is a promising, effective, well-tolerated and safe treatment option for migraine with and without aura, episodic or chronic.

Chemotherapy-induced peripheral neuropathy affects nearly half of adult cancer patients; a new review finds that there is currently no way to predict who will be affected.

This yellow CSF was drawn from an HIV-positive man who presented with status epilepticus. What is the most likely cause?

These review articles published in 2014 cover a variety of headache issues, and all are free courtesy of PubMed. Take a look.

Recovery from a paralyzed limb may be enhanced by a combination of these elements.

New research sheds light on epilepsy concerns, particularly the link between cardiac abnormalities and sudden unexpected death.

Get to the root of the latest research findings on nervous system disorders and test your brainpower with this quick 5-question quiz.

Identification of a brain circuit implicated in Alzheimer disease and schizophrenia could aid in comprehension of brain disorders and point to prevention strategies.

Pain relief is better with a triple combination medication that includes acetaminophen than with acetaminophen by itself, researchers found, suggesting a new therapeutic option.

Study results suggest that more stimulating work environments may help people retain their cognitive abilities.

The use of a stroke emergency mobile unit speeds thrombolysis and thus improves short-term outcomes, with no risk to patients’ safety.

The ketogenic and the modified Atkins diets, high in fat and low in carbohydrates, could reduce these seizures, suggesting that clinicians bring them into the treatment discussion.

The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.

These findings advance knowledge about the link between brain inflammation and the progression of brain disorders and suggest possible targets for future treatments.

Approved for patients with relapsing forms of MS, the drug generally should be reserved for those who have had an inadequate response to 2 or more drugs indicated for MS treatment.

Up until now, these treatments have not produced promising efficacy results in clinical trials. MRI could show the way.

As more treatments become available, patients will have more preferences and will play a more prominent role in directing choices.

Some very recent research findings have added to the literature on the associations between migraine and depression, anxiety, and other disorders. Highlights here.

Determining who is at risk for MS remains difficult, and symptoms may take time to develop even in patients who already have some destroyed myelin. MRI may help.

Could the common herpes simplex virus be associated with Alzheimer disease? These researchers think it is possible.

New study findings do not suggest a need for a change in vaccine policy, but even a small increased risk could have an effect on public health.

Here: 5 new things to know about stroke -- its link with perioperative A-fib; the danger of cocaine; rehab possibilities with an Alzheimer drug; reducing stroke risk with potassium; and a potential screen for occult A-fib after cryptogenic stroke.

Why ask patients to “spit in a cup”? Statistically significant protein differences have been found in Alzheimer disease saliva, and trends have been observed for Parkinson disease.

Serum testing for NMDAR and other autoantibodies is fraught with pitfalls, and careful clinical consideration is important.